Megakaryoblastic leukemia cell line MOLM-16 derived from minimally differentiated acute leukemia with myeloid/NK precursor phenotype

Leukemia Research

Volumn 27, Issue 2, 2003, Pages 165-171

  Matsuo, Yoshinobu ^a   Drexler, Hans G ^b   Kaneda, Kinuyo ^c   Kojima, Kensuke ^c   Ohtsuki, Yuji ^d   Hara, Masamichi ^e   Yasukawa, Masaki ^f   Tanimoto, Mitsune ^c   Orita, Kunzo ^a  

^a HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^b LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d KOCHI MEDICAL SCHOOL   (Japan)

^e EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^f EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute minimally differentiated leukemia; Megakaryoblastic cell line; Myeloid NK precursor leukemia

Indexed keywords

CD151 ANTIGEN; CD31 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD36 ANTIGEN; CD56 ANTIGEN; CD61 ANTIGEN; CD63 ANTIGEN; CD7 ANTIGEN; CD9 ANTIGEN; FIBRINOGEN; FIBRINOGEN RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; MICROSOMAL AMINOPEPTIDASE; MILODISTIM; PADGEM PROTEIN; PEROXIDASE; THROMBOSPONDIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS MEMBRANE; CHROMOSOME 21Q; CHROMOSOME 6; CHROMOSOME 8; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; LEUKEMIA CELL LINE; MEGAKARYOBLAST; NATURAL KILLER CELL; PHENOTYPE; PRECURSOR; PRIORITY JOURNAL; RELAPSE;

AGED; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 8; CHROMOSOMES, HUMAN, PAIR 9; CYTOGENETIC ANALYSIS; CYTOKINES; FEMALE; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; MICROSCOPY, ELECTRON, SCANNING; MYELOID CELLS; RECURRENCE; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0037297064     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00081-4     Document Type: Article

References (23)

1. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R.et al. Proposals for the classification of the acute leukaemias: French-American-British (FAB) Cooperative Group. Br. J. Haematol. 33:1976;451-458.
2. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R.et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann. Int. Med. 103:1985;620-625.
3. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R.et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Br. J. Haematol. 78:1991;325-329.
4. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R.et al. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7): a report of the French-American-British Cooperative Group. Ann. Int. Med. 103:1985;460-462.
5. - myeloid/NK cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood. 84:1994;244-255.
6. + myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood. 90:1997;2417-2428.
7. Kaashoek J.G.J., Mout R., Falkenburg J.H.F., Willemze R., Fibbe W.E., Landegent J.E. Cytokine production by the bladder carcinoma cell line 5637: rapid analysis of mRNA expression levels using a cDNA-PCR procedure. Lymphokine Cytokine Res. 10:1991;231-235.
8. Hu Z.-B., Ma W., Zaborski M., MacLeod R.A.F., Quentmeier H., Drexler H.G. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3. Leukemia. 10:1996;1025-1040.
9. Drexler H.G., Matsuo Y. Guidelines for the characterization and publication of human malignant hematopoietic cell lines. Leukemia. 13:1999;835-842.
10. Takeuchi S., Sugito S., Uemura Y., Miyagi T., Kubonishi I., Taguchi H.et al. Acute megakaryoblastic leukemia: establishment of a new cell line (MKPL-1) in vitro and in vivo. Leukemia. 6:1992;588-594.
11. Anderson W.A., Trantalis J., Kang Y.H. Ultrastructural localization of endogenous mammary gland peroxidase during lactogenesis in the rat results tannic acid-formaldehyde-glutalaldehyde fixation. J. Histochem. Cytochem. 23:1975;295-302.
12. Matsuo Y., Drexler H.G., Takeuchi M., Orita K. A novel biphenotypic B-cell precursor leukemia cell line (NALM-29) carrying t(9;22)(q34;q11) established from a patient with acute leukemia. Leuk. Res. 23:1999;731-740.
13. Matsuo Y., Drexler H.G., Takeuchi M., Orita K. Novel B-cell precursor leukemia sister cell lines, NALM-33 and NALM-34, established from a patient with acute lymphoblastic leukemia. Leuk. Lymph. 35:1999;513-526.
14. Matsuo Y., Drexler H.G., Nishizaki C., Harashima A., Fukuda S., Kozuka T.et al. Human bone marrow stroma-dependent myeloma cell line MOLP-5 derived from a patient in leukaemic phase of multiple myeloma. Br. J. Haematol. 109:2000;54-63.
15. Matsuo Y., MacLeod R.A.F., Uphoff C.C., Drexler H.G., Nishizaki C., Katayama Y.et al. Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23). Leukemia. 11:1997;1469-1477.
16. Drexler HG, Dirks WG, MacLeod RAF, Quentmeier H, Steube KG, Uphoff CC, editors. DSMZ catalogue of human and animal cell lines. 8th ed. Germany: Braunschweig, 2001.
17. Drexler HG, Uphoff CC. Contamination of cell culture, mycoplasma. In: Spier E, et al., editors. The encyclopedia of cell technology. New York: Wiley, 2000. p. 609-27.
18. Häne B., Tümmler M., Jäger K., Schleithoff L., Janssen J.W.G., Drexler H.G. Differences in DNA fingerprints of continuous leukemia-lymphoma cell lines from different sources. Leukemia. 6:1992;1129-1133.
19. Matsuo Y., Nishizaki C., Drexler H.G. Efficient DNA fingerprinting method for the identification of cross-contamination of cell lines. Human Cell. 12:1999;149-154.
20. Micallef M., Matsuo Y., Takayama K., Ariyasu T., Otani T., Minowada J. Differential platelet-associated factor gene expression by a panel of human cell lines with megakaryoblastic properties after treatment with phorbol myristate acetate. Hematol. Oncol. 12:1994;163-174.
21. Inaba T., Shimazaki C., Sumikuma T., Ochiai N., Okano A., Hatsuse M. Clinicopathological features of myeloid/natural killer (NK) cell precursor acute leukemia. Leuk. Res. 25:2001;109-113.
22. Suzuki R., Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia. Leuk. Res. 23:1999;615-624.
23. Suzuki R., Murata M., Kami M., Ohtake S., Asou N., Kodera Y. Myeloid/NK cell precursor acute leukemia is a distinct subtype of AML-M0. Blood. 98:2001;460.